News Sentiment

ERIS sentiment intelligence

Eris Lifesciences Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 28 relevant articles
Exchange NSI India
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 1431.20 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 28

directly relevant articles

Source quality 10

high-authority source matches

Trend context Trend inactive

+0.0% over one week, +1.9% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Eris Lifesciences Ltd Actuals & Estimates (NSE:ERIS)

Market Reaction

Balanced read

52/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend inactive 1.9% over four weeks
Fair value 14.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 21
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 28
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
scanx.trade 9
simplywall.st 4
Business Standard 3
Moneycontrol.com 3
CNBC TV18 2
The Economic Times 2
TradingView 1
Investing.com India 1

Event Lens

What the news is about

Classified themes
Market update 15
Deals and strategy 5
Earnings 3
Analyst action 3
Regulatory and legal 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-28 of 28